NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/26/2025
Back to search
Official data from USPTO
AVERITAS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
08/27/2025
Trademark type
Combined
Nice classes
41
Filing date
02/09/2023
Registration date
08/26/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/26/2025
Last transaction
08/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-07-00
First use in commerce
08/01/2023
Drawing code
3
Owner type
03
Owner location
Morristown, NJ
Examiner
CASE, LEIGH
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "Averitas" on the right side and a concentric circular design made up of dots on the left, and the dots partially encircles the letters "Av".
Holders and representatives
Holders
Averitas Pharma, Inc.
Representatives
Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Publishing and issuing of scientific papers in the field of medicine and pharmaceuticalsespecially for pharmaceutical companiespharmacistsphysicianspatientshealth insurance companies and their professional associations; Providing onlinenon-downloadable educational videos in the fields of pain treatment and disease management; Providing educational materials in the fields of pain treatment and disease management in the nature of patient guides and self-help guides
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/26/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/01/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/14/2025
IUAF
USE AMENDMENT FILED
06/25/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/25/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/27/2025
EX3G
SOU EXTENSION 3 GRANTED
05/27/2025
EEXT
SOU TEAS EXTENSION RECEIVED
05/20/2025
EXT3
SOU EXTENSION 3 FILED
05/19/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/26/2025
EX2G
SOU EXTENSION 2 GRANTED
02/26/2025
EXT2
SOU EXTENSION 2 FILED
02/03/2025
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2025
NOAC
CORRECTED NOA E-MAILED
08/12/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
08/12/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/06/2024
EX1G
SOU EXTENSION 1 GRANTED
08/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/06/2024
EXT1
SOU EXTENSION 1 FILED
08/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/02/2024
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
07/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/04/2024
DRRR
DIVISIONAL REQUEST RECEIVED
05/02/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/02/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2023
DOCK
ASSIGNED TO EXAMINER
11/08/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2023
NWAP
NEW APPLICATION ENTERED
02/13/2023
Continuous trademark protection
Get notified about every new filing that threatens AVERITAS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.